Literature DB >> 9169406

Developmental regulation of presenilin-1 processing in the brain suggests a role in neuronal differentiation.

H Hartmann1, J Busciglio, K H Baumann, M Staufenbiel, B A Yankner.   

Abstract

Most cases of early-onset familial Alzheimer's disease are caused by mutations in the presenilin genes. Presenilin-1 (PS1) is subject to proteolytic cleavage resulting in the accumulation of N- and C-terminal fragments. In this report, we show that the proteolytic cleavage of PS1 is developmentally regulated in the brain. Low levels of full-length PS1 and higher levels of 30-kDa N-terminal and 20-kDa C-terminal fragments are identified at all developmental stages in the rat brain. However, in the adult brain, additional 36-kDa N-terminal and 14-kDa C-terminal fragments appear and become major PS1 species. Alternative N-terminal PS1 fragments also appear in the adult human brain, but are more heterogenous than in the rat brain. The alternative PS1 fragments are not detected at significant levels in rat or human peripheral tissues that express PS1. The alternative cleavage of PS1 is also detected in primary cultures of rat hippocampal neurons, but not in astrocytes, and is induced by neuronal differentiation. Furthermore, alternative PS1 cleavage is detected in rat PC12 cells and human neuroblastoma SH-SY5Y cells following induction of neuronal differentiation. These results suggest that an alternative pathway of PS1 proteolytic processing is induced in the brain by neuronal differentiation. PS1 may therefore play an important role in brain development and neuronal function, which may relate to the brain-specific pathological effects of PS1 mutations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9169406     DOI: 10.1074/jbc.272.23.14505

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis: a review.

Authors:  R A Nixon; A M Cataldo; P M Mathews
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

Review 2.  Metabolism of presenilins.

Authors:  G Thinakaran
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

3.  Contrasting role of presenilin-1 and presenilin-2 in neuronal differentiation in vitro.

Authors:  C S Hong; L Caromile; Y Nomata; H Mori; D E Bredesen; E H Koo
Journal:  J Neurosci       Date:  1999-01-15       Impact factor: 6.167

4.  On the spurious endoproteolytic processing of the presenilin proteins in cultured cells and tissues.

Authors:  N N Dewji; C Do; S J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

5.  Neuronal localization of presenilin-1 and association with amyloid plaques and neurofibrillary tangles in Alzheimer's disease.

Authors:  J Busciglio; H Hartmann; A Lorenzo; C Wong; K Baumann; B Sommer; M Staufenbiel; B A Yankner
Journal:  J Neurosci       Date:  1997-07-01       Impact factor: 6.167

6.  Developmental expression of wild-type and mutant presenilin-1 in hippocampal neurons from transgenic mice: evidence for novel species-specific properties of human presenilin-1.

Authors:  L Lévesque; W Annaert; K Craessaerts; P M Mathews; M Seeger; R A Nixon; F Van Leuven; S Gandy; D Westaway; P St George-Hyslop; B De Strooper; P E Fraser
Journal:  Mol Med       Date:  1999-08       Impact factor: 6.354

7.  Preliminary array analysis reveals novel genes regulated by ovarian steroids in the monkey raphe region.

Authors:  Arubala P Reddy; Cynthia L Bethea
Journal:  Psychopharmacology (Berl)       Date:  2005-02-25       Impact factor: 4.530

8.  Ubiquilin regulates presenilin endoproteolysis and modulates gamma-secretase components, Pen-2 and nicastrin.

Authors:  Leann K Massey; Alex L Mah; Mervyn J Monteiro
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

9.  Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.

Authors:  A M Cataldo; C M Peterhoff; J C Troncoso; T Gomez-Isla; B T Hyman; R A Nixon
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

10.  Eicosapentaenoic acid (EPA) increases cell viability and expression of neurotrophin receptors in retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cells.

Authors:  Wei Kou; Dirk Luchtman; Cai Song
Journal:  Eur J Nutr       Date:  2008-03-23       Impact factor: 5.614

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.